Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Syrris’ Versatile Atlas Batch Reactor System Makes Polymerization Easier

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Petroleum and petrochemical provider PTT is reaping the benefits of the Atlas lab scale chemistry reactor system from Syrris, simplifying the production of catalysts for polyolefins.

Supabhorn Khaubunsongserm, a researcher in the process technology research department, explained: “We synthesize catalysts for the production of polyolefins such as polyethylene and polypropylene, and test the polymerization in slurry and gas phase processes. To help with this work, we have invested in Atlas modular products, which are very adaptable and can form a wide range of chemical reactors. We run two Atlas 3 bar reactor systems in parallel, and can quickly and easily configure the reactors for advanced applications such as calorimetry and crystallization control. The whole system is controlled by the intuitive Atlas Parallel Software, which automatically detects which apparatus is connected.”

“Syrris offers a variety of different vessels – including triple-jacketed vessels and round bottom flasks – which makes it easy to scale up reactions. Our Atlas reactors are in use every working day, and the system is very reliable. It offers great reproducibility, and its glass jacketed reactors allow us to follow both the polymerization reaction and the synthesis process. We also receive good support from both Sithiphorn, our local distributor, and Syrris, which we really appreciate; they always care about the little things that are important to the customer, and work with them to meet the specific demands of their applications.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!